Breaking News Instant updates and real-time market news.

IRWD

Ironwood

$10.86

-0.24 (-2.16%)

12:25
06/12/19
06/12
12:25
06/12/19
12:25

Ironwood participates in a conference call with JPMorgan

Life Science Tools & Diagnostics Analyst Joseph holds a conference call with CEO Eltoukhy on June 12 at 1 pm hosted by JPMorgan.

  • 12

    Jun

IRWD Ironwood
$10.86

-0.24 (-2.16%)

02/25/19
HCWC
02/25/19
UPGRADE
Target $14
HCWC
Neutral
Ironwood upgraded to Neutral from Sell at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju upgraded Ironwood Pharmaceuticals to Neutral and raised his price target for the shares to $14 from $11.50. The analyst anticipates "moderate growth" in Linzess within the U.S. market going forward, as well as accelerating contributions from ex-U.S. territories, particularly China. Ironwood's performance in the most recent quarter handily beats estimates, he points out.
02/26/19
SPIN
02/26/19
INITIATION
Target $18
SPIN
Buy
Ironwood initiated with a Buy at Spin-Off Research
Spin-Off Research initiated Ironwood with a Buy and $18 price target.
03/27/19
MSCO
03/27/19
UPGRADE
MSCO
Equal Weight
Ironwood upgraded to Equal Weight from Underweight at Morgan Stanley
03/27/19
MSCO
03/27/19
UPGRADE
Target $14
MSCO
Equal Weight
Morgan Stanley upgrades Ironwood to Equal Weight on more stable Linzess growth
Morgan Stanley analyst David Lebowitz upgraded Ironwood to Equal Weight from Underweight, citing his view that Linzess growth will stabilize after multiple quarters of deceleration. The withdrawal of generic MiraLAX in November 2018 will bring new patients in the near-term and new Phase 3 data expected by mid year should allow for new claims of reducing pain, discomfort and bloating, which Lebowitz thinks will bring new patients on board and help sales. Additionally, the company's spinoff of Cyclerion, expected to be completed on April 1, should lower costs and contribute to profitability, the analyst said. He raised his price target on Ironwood shares to $14 from $11.

TODAY'S FREE FLY STORIES

VKTX

Viking Therapeutics

$7.94

-0.07 (-0.87%)

06:02
06/25/19
06/25
06:02
06/25/19
06:02
Initiation
Viking Therapeutics initiated  »

Viking Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

CTRP

Ctrip

$36.43

0.37 (1.03%)

06:00
06/25/19
06/25
06:00
06/25/19
06:00
Hot Stocks
Ctrip enters strategic partnership with Tourism Fiji »

Ctrip has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$101.39

-3.73 (-3.55%)

, VKTX

Viking Therapeutics

$7.94

-0.07 (-0.87%)

05:58
06/25/19
06/25
05:58
06/25/19
05:58
Initiation
Madrigal Pharmaceuticals, Viking Therapeutics, Genfit initiated  »

Madrigal Pharmaceuticals…

MDGL

Madrigal Pharmaceuticals

$101.39

-3.73 (-3.55%)

VKTX

Viking Therapeutics

$7.94

-0.07 (-0.87%)

GNFT

Genfit

$20.19

-0.02 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

RGEN

Repligen

$81.92

-1.09 (-1.31%)

05:55
06/25/19
06/25
05:55
06/25/19
05:55
Conference/Events
Repligen management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

NRCG

NRC Group

$11.04

2.23 (25.31%)

, ECOL

US Ecology

$57.37

-5.38 (-8.57%)

05:54
06/25/19
06/25
05:54
06/25/19
05:54
Downgrade
NRC Group, US Ecology rating change  »

NRC Group downgraded to…

NRCG

NRC Group

$11.04

2.23 (25.31%)

ECOL

US Ecology

$57.37

-5.38 (-8.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XHR

Xenia Hotels

$20.41

-0.55 (-2.62%)

05:45
06/25/19
06/25
05:45
06/25/19
05:45
Initiation
Xenia Hotels initiated  »

Xenia Hotels initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCE

Arco Platform

$43.38

-2.35 (-5.14%)

05:41
06/25/19
06/25
05:41
06/25/19
05:41
Initiation
Arco Platform initiated  »

Arco Platform initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$129.65

-1.32 (-1.01%)

, EOLS

Evolus

$13.69

0.13 (0.96%)

05:40
06/25/19
06/25
05:40
06/25/19
05:40
Recommendations
Allergan, Evolus analyst commentary at Mizuho »

Allergan price target…

AGN

Allergan

$129.65

-1.32 (-1.01%)

EOLS

Evolus

$13.69

0.13 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

QSR

Restaurant Brands

05:39
06/25/19
06/25
05:39
06/25/19
05:39
Initiation
Restaurant Brands initiated  »

Restaurant Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$83.65

-0.16 (-0.19%)

05:39
06/25/19
06/25
05:39
06/25/19
05:39
Initiation
Starbucks initiated  »

Starbucks initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

  • 09

    Jul

DPZ

Domino's Pizza

05:39
06/25/19
06/25
05:39
06/25/19
05:39
Initiation
Domino's Pizza initiated  »

Domino's Pizza…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 13

    Nov

SHAK

Shake Shack

05:39
06/25/19
06/25
05:39
06/25/19
05:39
Initiation
Shake Shack initiated  »

Shake Shack initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 09

    Jul

  • 14

    Aug

MCD

McDonald's

05:39
06/25/19
06/25
05:39
06/25/19
05:39
Initiation
McDonald's initiated  »

McDonald's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CMG

Chipotle

05:39
06/25/19
06/25
05:39
06/25/19
05:39
Initiation
Chipotle initiated  »

Chipotle initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

PZZA

Papa John's

$44.13

-0.25 (-0.56%)

05:38
06/25/19
06/25
05:38
06/25/19
05:38
Initiation
Papa John's initiated  »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

WEN

Wendy's

$19.15

-0.22 (-1.14%)

05:38
06/25/19
06/25
05:38
06/25/19
05:38
Initiation
Wendy's initiated  »

Wendy's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 14

    Aug

  • 13

    Nov

YUM

Yum! Brands

$110.62

0.35 (0.32%)

05:38
06/25/19
06/25
05:38
06/25/19
05:38
Initiation
Yum! Brands initiated  »

Yum! Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNKN

Dunkin' Brands

$81.01

1.47 (1.85%)

05:38
06/25/19
06/25
05:38
06/25/19
05:38
Initiation
Dunkin' Brands initiated  »

Dunkin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

JACK

Jack in the Box

$82.83

-2.33 (-2.74%)

05:38
06/25/19
06/25
05:38
06/25/19
05:38
Initiation
Jack in the Box initiated  »

Jack in the Box initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 08

    Aug

PYX

Pyxus

$13.42

-1.1 (-7.58%)

05:36
06/25/19
06/25
05:36
06/25/19
05:36
Initiation
Pyxus initiated  »

Pyxus initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$137.80

0.86 (0.63%)

, AMZN

Amazon.com

$1,913.43

3.01 (0.16%)

05:30
06/25/19
06/25
05:30
06/25/19
05:30
Recommendations
Microsoft, Amazon.com analyst commentary at Jefferies »

Microsoft Azure likely…

MSFT

Microsoft

$137.80

0.86 (0.63%)

AMZN

Amazon.com

$1,913.43

3.01 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

XONE

ExOne

$7.38

-0.21 (-2.77%)

, SIEGY

Siemens

$0.00

(0.00%)

05:28
06/25/19
06/25
05:28
06/25/19
05:28
Hot Stocks
ExOne announces partnership with Siemens »

ExOne (XONE) announced a…

XONE

ExOne

$7.38

-0.21 (-2.77%)

SIEGY

Siemens

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPTN

SpartanNash

$10.87

-0.05 (-0.46%)

05:23
06/25/19
06/25
05:23
06/25/19
05:23
Initiation
SpartanNash initiated  »

SpartanNash initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DERM

Dermira

$9.51

-0.405 (-4.08%)

05:23
06/25/19
06/25
05:23
06/25/19
05:23
Hot Stocks
Almirall exercises option with Dermira to license rights to lebrikizumab in EU »

Almirall and Dermira…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLGHF

Telenet

$0.00

(0.00%)

05:15
06/25/19
06/25
05:15
06/25/19
05:15
Downgrade
Telenet rating change  »

Telenet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.